A Vita

Summary

Country: Italy

Publications

  1. doi request reprint Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care
    Antonio Vita
    University of Brescia, School of Medicine, Brescia, Italy Department of Mental Health, Spedali Civili Hospital, Brescia, Italy
    Schizophr Res 146:217-23. 2013
  2. ncbi request reprint Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies
    A Vita
    Department of Mental Health, University of Brescia, Italy
    Schizophr Res 82:75-88. 2006
  3. doi request reprint Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: a prospective controlled study in a real-world setting
    A Vita
    University of Brescia, School of Medicine, via Europa 11, 25123 Brescia, Italy
    Eur Psychiatry 26:276-83. 2011
  4. doi request reprint Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials
    Antonio Vita
    School of Medicine, University of Brescia, Italy
    J Clin Psychopharmacol 31:613-24. 2011
  5. pmc Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies
    A Vita
    School of Medicine, University of Brescia, Brescia, Italy
    Transl Psychiatry 2:e190. 2012
  6. pmc Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study
    Ferdinando Fusco
    Clinica Urologica Università Federico II, Napoli 80100, Italy
    Asian J Androl 11:629-37. 2009
  7. ncbi request reprint Hippocampal and amygdala volume reductions in first-episode schizophrenia
    A Vita
    Br J Psychiatry 190:271. 2007
  8. ncbi request reprint A genome-wide search for schizophrenia susceptibility genes
    S H Shaw
    Axys Pharmaceuticals, La Jolla, California, USA
    Am J Med Genet 81:364-76. 1998
  9. doi request reprint Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
    Rene S Kahn
    Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands
    Lancet 371:1085-97. 2008

Collaborators

Detail Information

Publications9

  1. doi request reprint Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care
    Antonio Vita
    University of Brescia, School of Medicine, Brescia, Italy Department of Mental Health, Spedali Civili Hospital, Brescia, Italy
    Schizophr Res 146:217-23. 2013
    ..The Schizophrenia Cognition Rating Scale (SCoRS), an interview-based assessment of cognition, has proved to be a valid measure of cognitive performance in patients with schizophrenia...
  2. ncbi request reprint Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies
    A Vita
    Department of Mental Health, University of Brescia, Italy
    Schizophr Res 82:75-88. 2006
    ....
  3. doi request reprint Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: a prospective controlled study in a real-world setting
    A Vita
    University of Brescia, School of Medicine, via Europa 11, 25123 Brescia, Italy
    Eur Psychiatry 26:276-83. 2011
    ..The improvement of such dysfunction by means of cognitive remediation interventions has become a relevant target in the care of schizophrenia...
  4. doi request reprint Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials
    Antonio Vita
    School of Medicine, University of Brescia, Italy
    J Clin Psychopharmacol 31:613-24. 2011
    ....
  5. pmc Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies
    A Vita
    School of Medicine, University of Brescia, Brescia, Italy
    Transl Psychiatry 2:e190. 2012
    ....
  6. pmc Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study
    Ferdinando Fusco
    Clinica Urologica Università Federico II, Napoli 80100, Italy
    Asian J Androl 11:629-37. 2009
    ..In conclusion sildenafil, vardenafil and tadalafil show similar efficacy in the clinical practice. However, patients receiving tadalafil display a lower risk to discontinue or change the treatment...
  7. ncbi request reprint Hippocampal and amygdala volume reductions in first-episode schizophrenia
    A Vita
    Br J Psychiatry 190:271. 2007
  8. ncbi request reprint A genome-wide search for schizophrenia susceptibility genes
    S H Shaw
    Axys Pharmaceuticals, La Jolla, California, USA
    Am J Med Genet 81:364-76. 1998
    ..0, allowing for heterogeneity. These regions will be saturated with additional markers and investigated in a new, larger set of families to test for replication...
  9. doi request reprint Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
    Rene S Kahn
    Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands
    Lancet 371:1085-97. 2008
    ..We aimed to compare the effectiveness of second-generation antipsychotic drugs with that of a low dose of haloperidol, in first-episode schizophrenia...